Outcome of Board Meeting

October 30, 2026 Listing Department Department of Corporate Services National Stock Exchange of India Limited BSE Limited Exchange Plaza Phiroze Jeejeebhoy Towers Bandra-Kurla Complex, Bandra (East) Dalal Street Mumbai – 400 051 Mumbai – 400 001 Symbol: MEDIASSIST Scrip Code: 544088 Dear Sir/ Madam, Subject: Outcome of the Board Meeting – October 30, 2026 The Board of Directors of Medi Assist Healthcare Services Limited (the “Company”) in their meeting held today i.e., October 30, 2026, have inter-alia, approved the following: 1) Unaudited Financial Results (Standalone and Consolidated) for the quarter & half year ended September 30, 2026 Approved unaudited financial results (standalone and consolidated) of the Company for the quarter & half year ended September 30, 2026. Copy of the unaudited financial results (standalone and consolidated) for the quarter & half year ended September 30, 2026 along with Limited Review Report issued by the Statutory Auditors of the Company are enclosed herewith as Annexure A. 2) Buyback of fully-paid up equity shares of the Company through the “tender offer” route The buyback of upto 11,59,199 (Eleven Lakh Fifty Nine Thousand One Hundred Ninety Nine) fully paid- up equity shares of the Company having a face value of INR 5/- (Indian Rupees Five only) each of the Company (“Equity Shares”), at a price of INR 425/- (Indian Rupees Four Hundred Twenty Five only) per Equity Share (“Buyback Price”) payable in cash for an amount not exceeding INR 49,26,59,575/- (Indian Rupees Forty Nine Crore Twenty Six Lakh Fifty Nine Thousand Five Hundred Seventy Five only) (“Buyback Size”), which is within the limit of 10% of the aggregate of the total paid-up Equity Share capital and free reserves of the Company under the Board approval route as per the Companies Act, 2013 and the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, as amended (the “SEBI Buyback Regulations”), on a proportionate basis through the “tender offer” route, using the stock exchange mechanism for acquisition of shares as prescribed under the SEBI Buyback Regulations and such other circulars or notifications issued by the Securities and Exchange Board of India (“SEBI”) and the Companies Act, 2013 and rules made thereunder, as amended from time to time, from all the shareholders/ beneficial owners of the Equity Shares (“Buyback”). The Buyback Size does not include transaction costs viz. brokerage costs, fees, turnover charges, applicable taxes such as securities transaction tax, goods and service tax, stamp duty, any expenses incurred or to be incurred for the Buyback like filing fees payable, advisors, legal fees, intermediary fees, public announcement publication expenses, printing, dispatch expenses and other incidental and related expenses. 3) The Company has constituted a committee called “Buyback Committee” and delegated its powers to do such acts, deeds, matters, and things as it may, in its absolute discretion, deem necessary, expedient, usual or proper in relation to the proposed Buyback. 4) Pursuant to Regulation 42 of the SEBI Listing Regulations and Regulation 9(i) of the SEBI Buyback Regulations, the Company has fixed Friday, November 20, 2026 as the record date (“Record Date”) for determining entitlement and the names of the equity shareholders who shall be eligible to participate in the Buyback. 5) The Board/ Buyback Committee may, 1 (one) working day prior to the Record Date, increase the Buyback Price and decrease the number of Equity Shares proposed to be bought back under the Buyback, such that there is no change in the Buyback Size, in terms of Regulation 5(via) of the SEBI Buyback Regulations. 6) The Board has noted the intention of the promoter and members of the promoter group of the Company, to not participate in the Buyback. 7) The Board has appointed, Ms. Rashmi BV, Company Secretary, as the compliance officer for the purposes of the proposed Buyback. The process, record date, timelines and other requisite details with respect to the Buyback will be set out in the public announcement and the letter of offer to be published in accordance with the SEBI Buyback Regulations. The details as required under Regulation 30 of SEBI Listing Regulations and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD/2/1/3762/2026 dated January 30, 2026, is set out in Annexure B. The Board Meeting commenced at 9.00 a.m. (IST) and concluded at 5.20 p.m. (IST). The trading window for dealing in shares of the Company is closed from October 01, 2026 till November 01, 2026. This outcome shall also be made available on the Company’s website at www.mediassist.in You are requested to take the same on record. Yours faithfully, For Medi Assist Healthcare Services Limited Rashmi B V Company Secretary & Compliance Officer ICSI Membership No: A38729 Encl.: As above MS K A Et Associates LLP SV Tower, No. 27, Floor 4 80 Feet Road, 6th Block, Koramangala Bengaluru 560095, INDIA (Formerly known as MS K A & Associates) Chartered Accountants Independent Auditor's Review Report on consolidated unaudited financial results of Medi Assist Healthcare Services Limited for the quarter and year-to-date pursuant to the Regulation 33 of the SEW (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended To the Board of Directors of Medi Assist Healthcare Services Limited 1. We have reviewed the accompanying Statement of consolidated unaudited financial results of Medi Assist Healthcare Services Limited (hereinafter referred to as 'the Holding Company') and its subsidiaries, (the Holding Company and its subsidiaries together referred to as the 'Group') for the quarter ended September 30, 2026 and the year to-date results for the period from April 01, 2026 to September 30, 2026 ('the Statement') attached herewith, being submitted by the Holding Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('the Regulations'). 2. This Statement, which is the responsibility of the Holding Company's Management and approved by the Holding Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 'Interim Financial Reporting' prescribed under Section 133 of the Companies Act, 2013 ('the Act') read with relevant rules issued thereunder ('Ind AS 34') and other recognised accounting principles generally accepted in India and is in compliance with the Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Act and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We also performed procedures in accordance with the circular issued by the Securities and Exchange Board of India under Regulation 33 (8) of the Regulations, to the extent applicable. Page 1 of 3 Registered Office: 602, Raheja Titanium, Western Express Highway, Goregaon (East), Mumbai-400063, Maharashtra, India Tel: +91 22 6974 0200 LLPTN: ACT-3789 Ahmedabad I Chandigarh I Chennai I Coimbatore I Goa I Gurugram I Hyderabad I Kochi I Kolkata I Mumbai I Pune www.mska.in MS K A Et Associates LLP (Formerly known [Showing first 8,000 characters — download PDF for full document]